AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Safirstein Metcalf LL Reminds Investors That A Class Action Has Been Filed Against American Renal Associates Holdings, Inc. - ARA

May 2, 2019

NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Safirstein Metcalf LLP reminds investors that a class action lawsuit has been filed on behalf of purchasers of the securities of American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE: ARA) between August 10, 2016 and March 27, 2019, inclusive (the “Class Period”).

If you purchased American Renal securities during the Class Period and would like more information about the shareholder class action, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email info@SafirsteinMetcalf.com.

If you wish to serve as a lead plaintiff, you must move the Court no later than May 28, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.

According to the lawsuit, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) American Renal’s financial statements for fiscal years 2014, 2015, 2016 and 2017 contained in its Annual Reports for the years ended December 31, 2016 and 2017, and its condensed consolidated financial statements in quarterly reports from 2016 through 2018 were false and could not be relied upon; (2) American Renal had material weaknesses in its internal control over financial reporting; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

About Safirstein Metcalf LLP

Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.

Attorney advertising. Prior results do not guarantee a similar outcome.

Safirstein Metcalf LLP Peter Safirstein, Esq The Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 1-800-221-0015